These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26782292)

  • 21. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinguishing between irritated seborrheic keratosis and squamous cell carcinoma in situ using BCL-2 and IMP3 immunohistochemistry.
    Richey JD; Deng AC; Dresser K; O'Donnell P; Cornejo KM
    J Cutan Pathol; 2018 Aug; 45(8):603-609. PubMed ID: 29726030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
    Takai T; Misago N; Murata Y
    J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer.
    Lu D; Yang X; Jiang NY; Woda BA; Liu Q; Dresser K; Mercurio AM; Rock KL; Jiang Z
    Am J Surg Pathol; 2011 Nov; 35(11):1638-45. PubMed ID: 21997684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keratoacanthoma and squamous cell carcinoma: study of PCNA and Le(Y) expression.
    Tsuji T
    J Cutan Pathol; 1997 Aug; 24(7):409-15. PubMed ID: 9274958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.
    Leblebici C; Pasaoglu E; Kelten C; Darakci S; Dursun N
    Oncol Lett; 2017 Apr; 13(4):2539-2548. PubMed ID: 28454431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.
    Toriseva M; Ala-aho R; Peltonen S; Peltonen J; Grénman R; Kähäri VM
    PLoS One; 2012; 7(3):e33041. PubMed ID: 22427941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
    Phillips P; Helm KF
    J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression pattern and functional role of REIC/Dkk-3 in the development of cutaneous squamous cell carcinoma.
    Shin JM; Choi DK; Kang HY; Sohn KC; Lee Y; Kim CD; Lee JH; Park BC
    J Dermatol Sci; 2016 Oct; 84(1):88-96. PubMed ID: 27354306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
    Findeis-Hosey JJ; Xu H
    Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
    Tan KB; Lee YS
    Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of TGFbeta receptor 1 expression differs between kras-mutated keratoacanthomas and squamous cell carcinomas of the skin.
    Berger F; Geddert H; Faller G; Werner M; Dimmler A
    Pathol Res Pract; 2014 Sep; 210(9):596-602. PubMed ID: 24954139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression.
    Pei X; Li M; Zhan J; Yu Y; Wei X; Guan L; Aydin H; Elson P; Zhou M; He H; Zhang H
    PLoS One; 2015; 10(4):e0124338. PubMed ID: 25919292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study.
    Jacobs MS; Persons DL; Fraga GR
    J Cutan Pathol; 2013 May; 40(5):447-54. PubMed ID: 23521519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subungual keratoacanthoma: analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma.
    Honma M; Kato N; Hashimoto M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Jan; 36(1):57-62. PubMed ID: 20456385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma.
    Chen K; Cornejo KM; Ye W; Wu Q; Liang J; Jiang Z
    Hum Pathol; 2013 Oct; 44(10):2126-31. PubMed ID: 23806529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
    Goldenhersh MA; Olsen TG
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.